t

AI Summary

The Invesco NASDAQ Biotech UCITS ETF (SBIO) announced its Net Asset Value (NAV) per share and number of shares in issue. As of the dealing date of 30 June 2022, the NAV per share was USD 38.4769, and 15,495,154.00 shares were in issue.

RNS Metadata

Date	1 Jul 2022
Time	13:03:46
Category	Corporate updates
ID	0591R

/Equities/XLON/SBIO/RNS

Net Asset Value(s)

RNS Number : 0591R

IVZ Nasdaq Biotech UCITS ETF$

01 July 2022

FUND:	Invesco NASDAQ Biotech UCITS ETF
DEALING DATE:	30-Jun-22
NAV PER SHARE:	USD:38.4769
NUMBER OF SHARES IN ISSUE:	15,495,154.00
CODE:	SBIO

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVFLFELDLILIIF

AI Summary

RNS Metadata

Date	1 Jul 2022
Time	13:03:46
Category	Corporate updates
ID	0591R

t

Company Information

AI Summary

RNS Metadata

Net Asset Value(s)

Company Information

AI Summary

RNS Metadata